InvestorsHub Logo
Followers 64
Posts 7226
Boards Moderated 0
Alias Born 05/28/2004

Re: Tonneke post# 82613

Friday, 05/10/2019 9:14:42 AM

Friday, May 10, 2019 9:14:42 AM

Post# of 111075
These were moved to February 2020 vs September 2018 is all I was saying.

Warrant Exchange
On February 28, 2019, Creative Medical Technology Holdings, Inc. (the “Company”) entered into three separate Exchange Agreements (each, an “Exchange Agreement”) with the holders (the “Warrant Holders”) of Common Stock Purchase Warrants issued by the Company in September 2018 and November 2018. Under each Exchange Agreement, the Company issued a convertible promissory note in the principal amount of $100,000 (an “Exchange Note”) to the Warrant Holder party to such Exchange Agreement in exchange for the cancellation of Common Stock Purchase Warrants held by such Warrant Holder, initially exercisable for an aggregate of 3,232,912 shares of the Company’s common stock. The exchanges were effected pursuant to Sections 3(a)(9) and 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) promulgated thereunder.

Each Exchange Note matures on February 28, 2020, bears interest at a rate of 8% per annum, and beginning 31 days after the closing date, is convertible into shares of the Company’s common stock at a conversion price equal to 65% of the Market Price of the common stock. “Market Price” as defined in each Exchange Note means the average of the two lowest “VWAPs” (as defined) of the Company’s common stock during the 15 trading days preceding the applicable conversion date.

The information set forth above is qualified in its entirety by reference to the actual terms of the Exchange Agreements and Exchange Notes, forms of which are attached hereto as Exhibits 10.1 and 4.1, respectively, and which are incorporated herein by reference.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News